MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-HR-05-0011860
BKRS Pharma Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.8 Cr
▼ 15% YoY
Net profit · FY 2025
₹29.53 Lakh
Net margin 2%
EBITDA · FY 2025
₹2.61 Cr
EBITDA margin 17.6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹9.26 Cr
Satisfied ₹10.6 Cr
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About BKRS Pharma Private Limited
Data last updated:
BKRS Pharma Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2012PTC045971. Its GSTIN is 06AAFCB0791F1ZW (Haryana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Sumeer Koul and Beenu Koul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No 421 Tower B Spazedge Commercial Complex Sohna Road Sector 47, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.8 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹29.53 Lakh (net margin 2%) and EBITDA of ₹2.61 Cr (EBITDA margin 17.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹9.26 Cr and satisfied charges of ₹10.6 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
BKRS Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HR-05-0011860). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bkrspharma.com.
Company Details of BKRS Pharma Private Limited
CIN U24230HR2012PTC045971
Registration Number 045971
Incorporation Date 17 May 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-HR-05-0011860
Key People
Sumeer Koul Director Beenu Koul Director Recognitions & Rankings of BKRS Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No 421 Tower B Spazedge Commercial Complex Sohna Road Sector 47, Gurgaon, Haryana, India – 122001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
BKRS Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of BKRS Pharma Private Limited
The main business activity of BKRS Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of BKRS Pharma Private Limited FY 2025 filings available
BKRS Pharma Private Limited reported revenue of ₹14.8 Cr (down 15% YoY) for FY 2025.
Revenue · FY 2025
₹14.8 Cr ▼ 15%
Net profit · FY 2025
₹29.53 Lakh margin 2%
EBITDA · FY 2025
₹2.61 Cr margin 17.6%
Compounded Annual Growth Rate (CAGR) of BKRS Pharma Private Limited
Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 3%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 33%
5 years · compounded
▲ 25%
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of BKRS Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.53 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of BKRS Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of BKRS Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of BKRS Pharma Private Limited
BKRS Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumeer Koul Also directs: Karbon Pharma Private Limited | Director | 27 Mar 2014 | 12 Years 6 Months | Current |
| Beenu Koul | Director | 17 May 2012 | 14 Years 5 Months | Current |
Peer Comparison of BKRS Pharma Private Limited
BKRS Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tuttsan Pharma Private Limited | ₹14.87 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Kalol, Gujarat, India |
| Kureasia Pharma Private Limited | ₹14.86 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | New Delhi, Delhi, India |
| B D Pharmaceutical Works Private Limited | ₹14.82 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Rakesh Healthcare (India) Limited | ₹14.82 Cr (FY 2024) | •••• | •••• | 320.0% | •••• | Kalol, Gujarat, India |
| Vav Lipids Private Limited | ₹14.81 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
| BKRS Pharma Private Limited this company | ₹14.8 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Gurgaon, Haryana, India |
| Sridhara Laboratories Private Limited | ₹14.8 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Hyderabad, Telangana, India |
| Whitefield Chemtech Private Limited | ₹14.79 Cr (FY 2017) | •••• | •••• | 108.0% | •••• | Vadodara, Gujarat, India |
| Adonis Phytoceuticals Private Limited | ₹14.78 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| Resonant Pharmaceuticals Private Limited | ₹14.67 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Navagam, Gujarat, India |
| Crescent R&D Private Limited | ₹14.67 Cr (FY 2024) | •••• | •••• | -57.0% | •••• | Sriperumbudur, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below BKRS Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of BKRS Pharma Private Limited
BKRS Pharma Private Limited is audited by NIKHIL RELAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIKHIL RELAN & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of BKRS Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of BKRS Pharma Private Limited
Open charges
₹9.26 Cr
Satisfied charges
₹10.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2025 | Others | ₹7.41 Cr | Open |
| 18 Apr 2025 | Others | ₹1.85 Cr | Open |
| 29 Jun 2024 | Others | ₹1 Cr | Satisfied |
| 10 Mar 2023 | Sidbi | ₹7.5 Cr | Satisfied |
| 20 Sep 2022 | Others | ₹75 Lakh | Satisfied |
Total charge records: 7 View all charges
Legal Cases of BKRS Pharma Private Limited
BKRS Pharma Private Limited has 1 court case on record: 1 filed by BKRS Pharma. All case is pending. Status as checked on 02 Oct 2026.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Civil suit | Filed by the company against Elfin Pharma Private Limited | Pending |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at BKRS Pharma Private Limited
Employment history and EPFO contributions of people linked to BKRS Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on BKRS Pharma Private Limited
BKRS Pharma Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Preeti Bansal ceased to be Additional Director on 30 Sep 2018.
Charges
A charge registered on 29 Jun 2024 via Charge ID 100968315 with Others was fully satisfied on 13 Nov 2025.
AGM
Bkrs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 1.85 Cr registered on 18 Apr 2025 with Charge ID 101091151 was modified on 20 Sep 2025.
Charges
A charge registered on 20 Sep 2022 via Charge ID 100607838 with Others was fully satisfied on 09 Jun 2025.
Charges
A charge registered on 10 Mar 2023 via Charge ID 100683570 with Sidbi was fully satisfied on 29 May 2025.
Charges
A charge with Others amounted to Rs. 7.41 Cr with Charge ID 101102828 was registered on 26 Apr 2025.
Charges
A charge with Others amounted to Rs. 1.85 Cr with Charge ID 101091151 was registered on 18 Apr 2025.
Filing
Bkrs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100968315 was registered on 29 Jun 2024.
Charges
A charge with Sidbi amounted to Rs. 7.50 Cr with Charge ID 100683570 was registered on 10 Mar 2023.
Charges
A charge registered on 16 Dec 2020 via Charge ID 100406189 with Others was fully satisfied on 28 Feb 2023.
Charges
A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100607838 was registered on 20 Sep 2022.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for BKRS Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by BKRS Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of BKRS Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of BKRS Pharma Private Limited
BKRS Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCB0791F1ZW | Haryana | Active | 01 Jul 2017 |
| 08AAFCB0791F1ZS | Rajasthan | Active | 14 Jun 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of BKRS Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BKRS Pharma Private Limited
BKRS Pharma is an active private limited company based in Gurgaon, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2012 (14+ years old) and is registered under CIN U24230HR2012PTC045971.
BKRS Pharma reported revenue of ₹14.8 Cr for FY 2025 (down 15% YoY).
BKRS Pharma has 2 current directors:
- Sumeer Koul - Director
- Beenu Koul - Director
BKRS Pharma reported a net profit of ₹29.53 Lakh (net margin 2%) and EBITDA of ₹2.61 Cr (EBITDA margin 17.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of BKRS Pharma is 3% over three years and 9% over five years. In the latest year (FY 2025) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of BKRS Pharma is 06AAFCB0791F1ZW, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAFCB0791F1ZS (Rajasthan).
The CIN (Corporate Identification Number) of BKRS Pharma is U24230HR2012PTC045971. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
BKRS Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
BKRS Pharma was incorporated on 17 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of BKRS Pharma by revenue are Tuttsan Pharma Private Limited, Kureasia Pharma Private Limited, B D Pharmaceutical Works Private Limited, Rakesh Healthcare (India) Limited, Vav Lipids Private Limited and 5 more, all in the Pharma industry (Formulations).
Preeti Bansal ceased to be Additional Director on 30 Sep 2018. Manmohan Bansal ceased to be Additional Director on 30 Sep 2017. Renu Singh ceased to be Director on 28 Mar 2014. BKRS Pharma has 5 board changes on record in total.